Zealand Pharma A/S (ZLDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,317 | 651 | 4,925 | 2,197 | 3,143 |
| Cost of Goods | 79 | -976 | 1,369 | 669 | 2,030 |
| Gross Profit | 1,238 | 1,627 | 3,556 | 1,528 | 1,113 |
| Operating Expenses | 58,408 | 52,154 | 42,551 | 39,447 | 37,994 |
| Operating Income | -57,090 | -51,504 | -38,626 | -37,250 | -36,851 |
| Interest Expense | -1,688 | -87 | 8,303 | 940 | 1,841 |
| Other Income | 13,694 | 11,947 | 4,495 | 4,702 | 184 |
| Pre-tax Income | -41,708 | -39,469 | -42,434 | -33,488 | -38,509 |
| Income Tax | -80 | -203 | -190 | -197 | -82 |
| Net Income Continuous | -41,628 | -39,267 | -42,244 | -33,291 | -38,427 |
| Net Income | $-41,628 | $-39,267 | $-42,244 | $-33,291 | $-38,427 |
| EPS Basic Total Ops | -0.59 | -0.56 | -0.67 | -0.54 | -0.65 |
| EPS Basic Continuous Ops | -0.59 | -0.56 | -0.67 | -0.54 | -0.65 |
| EPS Diluted Total Ops | -0.59 | -0.56 | -0.67 | -0.54 | -0.64 |
| EPS Diluted Continuous Ops | -0.59 | -0.56 | -0.67 | -0.54 | -0.64 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -0.56 | -0.67 | N/A | N/A |
| EBITDA(a) | $-56,227 | $-50,549 | $-37,659 | $-36,287 | $-36,851 |